Acyclovir Injection 500mg

Contraindications: Valacyclovir hypersensitivity.

Warnings/Precautions: Renal impairment: see literature. Maintain adequate hydration. Neurological or serious renal, hepatic, or electrolyte abnormalities, or significant hypoxia. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions: Avoid nephrotoxic drugs. Potentiated by probenecid.

Pharmacological Class: Nucleoside analogue.

Description

Indications for Acyclovir Inj:

Genital herpes (severe initial episodes in immunocompetent patients). Herpes simplex (in neonates, and as initial and recurrent treatment in immunocompromised patients). Herpes simplex encephalitis. Varicella zoster (immunocompromised patients).

Adult:

Give by IV infusion over 1 hour. Mucocutaneous herpes simplex (immunocompromised): 5mg/kg every 8 hours for 7 days. Genital herpes: 5mg/kg every 8 hours for 5 days. Encephalitis: 10mg/kg every 8 hours for 10 days. Varicella zoster (immunocompromised): 10mg/kg every 8 hours for 7 days. All: max 20mg/kg every 8 hours. Obese: dose based on ideal body weight. Renal impairment: CrCl 250mL/min: give dose every 12 hours; CrCl 10–25mL/min: give dose every 24 hours; CrCl<10mL/min: reduce dose by 50% and give every 24 hours. Coincide a dose for after hemodialysis.

Children:

Give by IV infusion over 1 hour. Neonatal (birth mos) herpes simplex: 10mg/kg every 8 hours for 10 days (doses of 20mg/kg every 8 hours have been used; see literature). Mucocutaneous herpes simplex (immunocompromised): 10mg/kg every 8 hours for 7 days. Encephalitis: 12yrs: 20mg/kg every 8 hours for 10 days. Varicella zoster: <12yrs (immunocompromised): 20mg/kg every 8 hours for 7 days. All: max 20mg/kg every 8 hours. Obese: dose based on ideal body weight. Renal impairment: CrCl 25 50mL/min: give dose every 12 hours; CrCl 10 25mL/min: give dose every 24 hours; CrCl <10mL/min: reduce dose by 50% and give dose every 24 hours. Coincide a dose for after hemodialysis.

Contraindications:

Valacyclovir hypersensitivity.

Warnings/Precautions:

Renal impairment: see literature. Maintain adequate hydration. Neurological or serious renal, hepatic, or electrolyte abnormalities, or significant hypoxia. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Avoid nephrotoxic drugs. Potentiated by probenecid.

Pharmacological Class:

Nucleoside analogue.

Adverse Reactions:

Inj site reactions, transient elevated BUN and serum creatinine, GI upset, pruritus, rash, CNS effects (esp. in elderly), elevated transaminases, hematologic abnormalities, renal failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in immunocompromised patients.

Storage Conditions:  Store it at room temperature.

Key Feature:

  • WHO-GMP Certified
  • Packaging can be customize
  • Hygienically packed
  • Balanced composition
  • Stability
  • Highly effective